INSUBCONTINENT EXCLUSIVE:
ARCT-154 or Kostaive, received approval in November 2023 and was introduced on October 1, 2024.This vaccine from San Diego-based
Nasdaq-listed Arcturus Therapeutics uses technology that enables injected mRNA to self-replicate in the body.Proponents claim it requires a
much smaller dose than conventional mRNA vaccines and provides longer-lasting immunity.Clinical trials in Vietnam involving over 16,000
(Photo Internet reproduction)Critics worry about potential long-term effects and the risk of shedding, where vaccinated individuals might
Japan and the adequacy of informed consent procedures.Safety concerns stem from the self-replicating nature of the vaccine and uncertainties
about how long the mRNA persists in the body.Some critics argue that this technology could potentially cause more severe adverse reactions
recent study in Japan has identified a significant connection between mRNA COVID-19 vaccines and heart issues, particularly in young
men.Keisuke Takada and his team analyzed a national database spanning nearly two decades.They found that myocarditis and pericarditis were
more common among young men after vaccination.Myocarditis was about 30 times more likely in vaccinated individuals than unvaccinated ones
Pericarditis was about 22 times more likely in vaccinated individuals compared to unvaccinated ones.These findings suggest a higher
frequency of severe cardiac events in certain populations.This triggers a reevaluation of vaccine use in higher-risk groups.The new vaccine
will target those aged 65 and older, as well as individuals aged 60-64 with high-risk conditions.(Dr
Robert Malone on the ARCT-154 or Kostaive vaccine)Approximately 4.27 million doses are expected to be supplied as part of the regular
vaccination program.Japan plans to manufacture the vaccine domestically, with production slated for Fukushima Prefecture.Public discourse
surrounding the vaccine has been intense, with calls for more comprehensive information about its benefits and risks.Some medical
professionals have ethical concerns about introducing new vaccine technology without long-term studiesSocial Pressure and Coercion
ExpectedCritics worry about social pressure or coercion to receive the vaccine
Robert Malone, a critic of mRNA vaccines, adds to the controversy.He claims Japanese authorities might prosecute those spreading
censorship and control.This situation highlights the challenges of balancing public health initiatives with addressing public concerns and
maintaining open scientific discourse.As Japan prepares to roll out this new vaccine, the debate continues to intensify, underscoring the
